Development of heat shock proteins with controlled distribution properties and their application to vaccine delivery

Yakugaku Zasshi

Volumn 127, Issue 2, 2007, Pages 293-300

  Nishikawa, Makiya ^a   Takemoto, Seiji ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antigen delivery; DNA vaccine; Heat shock protein; Intracellular trafficking; Pharmacokinetics

Indexed keywords

CANCER VACCINE; CHAPERONE; DNA; HEAT SHOCK PROTEIN 70; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TARGETING; GENE TARGETING; IMMUNE RESPONSE; LIVER CELL; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN BINDING; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CANCER VACCINES; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 33846839161     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.293     Document Type: Review

References (20)

1. Yamasaki Y., Sumimoto K., Nishikawa M., Yamashita F., Yamaoka K., Hashida M., Takakura Y., J. Pharmacol. Exp. Ther., 301, 467-477 (2002).
2. Shakushiro K., Yamasaki Y., Nishikawa M., Takakura Y., Immunology, 112, 211-218 (2004).
3. Ikenaga T., Yamasaki Y., Shakushiro K., Nishikawa M., Takakura Y., Vaccine, 22, 2609-2616 (2004).
4. Hartl F. U., Nature, 381, 571-579 (1996).
5. Zhu X., Zhao X., Burkholder W. F., Gragerov A., Ogata C. M., Gottesman M. E., Hendrickson W. A., Science, 272, 1606-1614 (1996).
6. Binder R. J., Han D. K., Srivastava P. K., Nat. Immunol., 1, 151-155 (2000).
7. Delneste Y., Magistrelli G., Gauchat J., Haeuw J., Aubry J., Nakamura K., Kawakami-Honda N., Goetsch L., Sawamura T., Bonnefoy J., Jeannin P., Immunity, 17, 353-362 (2002).
8. Srivastava P., Annu. Rev. Immunol., 20, 395-425 (2002).
9. Takemoto S., Nishikawa M., Takakura Y., Pharm. Res., 22, 419-426 (2005).
10. Delneste Y., Magistrelli G., Gauchat J., Haeuw J., Aubry J., Nakamura K., Kawakami-Honda N., Goetsch L., Sawamura T., Bonnefoy J., Jeannin P., Immunity, 17, 353-362 (2002).
11. Herz J., Strickland D. K., J. Clin. Invest., 108, 779-784 (2001).
12. Javid B., MacAry P. A., Oehlmann W., Singh M., Lehner P. J., Biochem. Soc. Trans., 32, 622-625 (2004).
13. Flynn G. C., Pohl J., Flocco M. T., Rothman J. E., Nature, 353, 726-730 (1991).
14. Moroi Y., Mayhew M., Trcka J., Hoe M. H., Takechi Y., Hartl F. U., Rothman J. E., Houghton A. N., Proc. Natl. Acad. Sci. U.S.A., 97, 3485-3490 (2000).
15. Udono H., Yamano T., Kawabata Y., Ueda M., Yui K., Int. Immunol., 13, 1233-1242 (2001).
16. Boussif O., Lezoualc'h F., Zanta M. A., Mergny M. D., Scherman D., Demeneix B., Behr J. P., Proc. Natl. Acad. Sci. U.S.A., 92, 7297-7301 (1995).
17. Thanaketpaisarn O., Nishikawa M., Yamashita F., Hashida M., Pharm. Res., 22, 883-891 (2005).
18. Kawase A., Kobayashi N., Isaji K., Nishikawa M., Takakura Y., Int. J. Pharm., 293, 291-301 (2005).
19. Kawase A., Isaji K., Yamaoka A., Kobayashi N., Nishikawa M., Takakura Y., Vaccine, 24, 5535-5545 (2006).
20. Belli F., Testori A., Rivoltini L., Maio M., Andreola G., Sertoli M. R., Gallino G., Piris A., Cattelan A., Lazzari I., Carrabba M., Scita G., Santantonio C., Pilla L., Tragni G., Lombardo C., Arienti F., Marchiano A., Queirolo P., Bertolini F., Cova A., Lamaj E., Ascani L., Camerini R., Corsi M., Cascinelli N., Lewis J. J., Srivastava P., Parmiani G., J. Clin. Oncol., 20, 4169-4180 (2002).